- Home
- TLSI vs EML Comparison
TLSI vs EML Comparison
Compare TLSI & EML Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- TLSI
- EML
- Stock Information
- Founded
- TLSI 2010
- EML 1858
- Country
- TLSI United States
- EML United States
- Employees
- TLSI N/A
- EML N/A
- Industry
- TLSI Medical Specialities
- EML Industrial Machinery/Components
- Sector
- TLSI Health Care
- EML Consumer Discretionary
- Exchange
- TLSI Nasdaq
- EML Nasdaq
- Market Cap
- TLSI 166.8M
- EML 171.1M
- IPO Year
- TLSI N/A
- EML N/A
- Fundamental
- Price
- TLSI $4.59
- EML $31.79
- Analyst Decision
- TLSI Strong Buy
- EML
- Analyst Count
- TLSI 3
- EML 0
- Target Price
- TLSI $12.67
- EML N/A
- AVG Volume (30 Days)
- TLSI 73.9K
- EML 32.8K
- Earning Date
- TLSI 11-12-2024
- EML 11-05-2024
- Dividend Yield
- TLSI N/A
- EML 1.37%
- EPS Growth
- TLSI N/A
- EML 65.47
- EPS
- TLSI N/A
- EML 1.92
- Revenue
- TLSI $24,736,000.00
- EML $273,702,675.00
- Revenue This Year
- TLSI $61.24
- EML N/A
- Revenue Next Year
- TLSI $47.32
- EML N/A
- P/E Ratio
- TLSI N/A
- EML $16.15
- Revenue Growth
- TLSI 67.75
- EML N/A
- 52 Week Low
- TLSI $3.32
- EML $16.10
- 52 Week High
- TLSI $10.42
- EML $35.78
- Technical
- Relative Strength Index (RSI)
- TLSI 34.61
- EML 61.99
- Support Level
- TLSI $4.54
- EML $29.73
- Resistance Level
- TLSI $5.08
- EML $31.99
- Average True Range (ATR)
- TLSI 0.35
- EML 1.07
- MACD
- TLSI -0.04
- EML 0.10
- Stochastic Oscillator
- TLSI 15.79
- EML 77.36
About TLSI TriSalus Life Sciences Inc.
TriSalus Life Sciences Inc is engaged in the research, development, and sales of innovative drug delivery technology and immune-oncology therapeutics to improve outcomes in difficult-to-treat liver and pancreatic cancer. It is developing and marketing two product lines Pressure Enabled Drug Delivery (PEDD) infusion systems, in use today, and an investigational agent, nelitolimod (SD-101), which shows potential to enhance immune system response in the treatment of hepatocellular cancer, pancreatic cancer and other liver solid tumors. TriNav is the newest therapy delivery device with SmartValve technology for the proprietary PEDD approach.
About EML Eastern Company (The)
The Eastern Co manages industrial businesses that design, manufacture, and sell engineered solutions to industrial markets. The company manages the financial, operational, and strategic performance of its businesses to increase cash generation, operating earnings, and long-term shareholder value. It operates in the United States and Other Countries and generates the majority of its revenue from the United States.